Here is their response:
Thank you for contacting the National Institute for Health and Clinical Excellence (NICE).
In July 2012 we advised you that your correspondence on the use of baclofen for alcohol addiction had been referred to colleagues in the NICE Topic Selection team. I have now been advised that this topic is currently being considered as a potential topic for our Evidence Summaries: unlicensed and off-label medicines (ESUOM) work programme. Evidence summaries are a new product from NICE that summarise the best available evidence for selected unlicensed and off-label medicines. You can read more about evidence summaries on our website
We expect to have an update on whether baclofen will progress as a topic for evidence summaries towards the end of March 2013, but it is important to note that there is no guarantee we will develop advice on this topic.
Regards
Teresa
Teresa Birch
Associate Director (Enquiry Handling and Internal Communications)
National Institute for Health and Clinical Excellence
Level 1A | City Tower | Piccadilly Plaza | Manchester M1 4BD | United Kingdom
Tel: 44 (0)845 003 7781 | Fax: 44 (0)845 003 7785
Web: National Institute for Health and Clinical Excellence
Comment